Photo from Kai-Cheng Hsu/LinkedIn
May 1, 2024, 01:32
Kai-Cheng Hsu: Our groundbreaking research on the ‘Utility of polygenic scores across diverse diseases in a hospital cohort for predictive modeling
Kai-Cheng Hsu, Chief Medical Officer of Biomedical Technology and Device Research Laboratories in Industrial Technology Research Institute, shared a post on LinkedIn:
“l am thrilled to announce that our groundbreaking research on the ‘Utility of polygenic scores across diverse diseases in a hospital cohort for predictive modeling’ has been published in Nature Communications! This pioneering study unlocks potential in precision medicine by showcasing how polygenic scores can dramatically enhance disease prediction and patient care strategies. A true milestone for our team, this publication underscores our commitment to revolutionizing healthcare through science.”
Additonal information.
Source: Kai Cheng Hsu/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19
Dec 21, 2024, 19:18
Dec 21, 2024, 18:59
Dec 21, 2024, 18:57
Dec 21, 2024, 18:54